CA
NZ
UK
AU
IND
US
● The framing points to a plunge, but there is no identifiable public catalyst behind the quoted move.
● CONMED occupies a corner of the medical-device world that rarely grabs headlines but quietly touches thousands of operating rooms every day.
Few small-cap biotechs enter aTrading sessioncarrying a brand-new name, and that is exactly where Cerenome, Inc. (NASDAQ:CNSY) finds itself. The company that used to trade as Plus Therapeutics adopted its new identity only weeks ago, and the shares have been choppy ever since. A …
Few small-cap oncology names carry as wide a gap between clinical ambition andMarket Valueas Context Therapeutics Inc. (NASDAQ: CNTX). The immuno-oncology developer trades near the $0.37 level with a market capitalization around $34 million, even as its pipeline of T-cell engaging bispecific antibodies advances …
● Cosmos Health has been trying to reframe its story from a volatile small-cap into a growing, internationally diversified healthcare and wellness business.
● Coya develops therapies designed to enhance the function of regulatory T cells (Tregs), immune cells that help control the inflammation implicated in diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
● Caribou Biosciences has become a case study in the gap between promising science and a punishing market for early-stage biotech.
Curis, Inc (NASDAQ:CRIS) has slipped again, and the pullback lands on a stock that has already endured a brutal multi-year decline. The Lexington, Massachusetts cancer-drug developer trades deep in micro-cap territory after repeated financings, yet its lead program keeps generating clinical headlines that draw …
● For a small-cap services company, trading tends to follow reported financial performance and sentiment toward the biotech funding cycle, since Champions' customers are the very drug developers whose research budgets rise and fall withCapitalavailability.
CuraScientific Corp (OTC:CSTF) sits at the intersection of two of the market's riskiest corners: sub-penny over-the-counter stocks and the cannabis consumer-products business. Trading at a fraction of a cent with aMarket Valuein the low thousands of dollars in the last closing session, the company …
Please wait processing your request...